Christopher Ho

1.4k citations
8 papers · 1.2k indexed · 1 hit paper · h-index 8

Christopher Ho

8 papers receiving 1.2k citations

Hit Papers

Identification of Telmisartan as a Unique Angiotensin II ...9272004202620112018250500750

Peers

Christopher Ho
Comparison fields: 5 of 91
  • Endocrinology, Diabetes and Metabolism 373
  • Biochemistry 146
  • Cardiology and Cardiovascular Medicine 452
  • Physiology 294
  • Pharmacology 156
Replace Nianning Qi with:
Nianning Qi United States
Yoshiko Tokutomi Japan
María Antonia Fortuño Spain
De‐Zai Dai China
Fung Ping Leung Hong Kong
Ming-Sheng Zhou China
Swenja Schuhmacher Germany
Mario Campagnola Italy
Kazuhiro Sonoda Japan
Kazuhisa Takeuchi Japan
Christopher Ho relative to Nianning Qi United States Nianning Qi's profile →
Citations per field
00.5×1.5×
Nianning Qi · 1×
Citations per year

Countries citing papers authored by Christopher Ho

Since Specialization
Citations

This map shows the geographic impact of Christopher Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Ho more than expected).

Fields of papers citing papers by Christopher Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Ho. The network helps show where Christopher Ho may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Ho Line = papers co-authored together Christopher Ho links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 201151
2 20108
3 200934
4 200831
5 200764
6 200642
7 200448
8
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activitybreakdown →
2004927

About Christopher Ho

Christopher Ho is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine, Clinical Biochemistry, Molecular Biology and Cancer Research, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Renin-Angiotensin System Studies (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Genetic Syndromes and Imprinting (1 paper), Mitochondrial Function and Pathology (1 paper), Retinoids in leukemia and cellular processes (1 paper) and Nuclear Receptors and Signaling (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (373 citations), Biochemistry (146 citations), Cardiology and Cardiovascular Medicine (452 citations), Physiology (294 citations) and Pharmacology (156 citations). Christopher Ho has collaborated with scholars based in United States, Japan and Czechia. Frequent co-authors include Theodore W. Kurtz, Stephen C. Benson, Harrihar A. Pershadsingh, Amar G. Chittiboyina, Prashant Desai, Mitchell A. Avery, Michal Pravenec, Nianning Qi, Jiaming Wang and Jiaming Wang. Their work appears in journals such as Hypertension, Journal of Hypertension, Genome Research, Journal of Medicinal Chemistry and Annals of Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026